Sacyr, S.A. (BME:SCYR) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Shareholders might have noticed that Sacyr, S.A. (BME:SCYR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.0% to €3.68 in the past week. It was a workmanlike result, with revenues of €1.2b coming in 2.1% ahead of expectations, and statutory earnings per share of €0.15, in line with analyst appraisals. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Following last week's earnings report, Sacyr's nine analysts are forecasting 2026 revenues to be €4.79b, approximately in line with the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of €4.81b and earnings per share (EPS) of €0.22 in 2026. Overall, while the analysts have reconfirmed their revenue estimates, the consensus now no longer provides an EPS estimate. This implies that the market believes revenue is more important after these latest results.

See our latest analysis for Sacyr

There's been no real change to the consensus price target of €4.45, with Sacyr seemingly executing in line with expectations. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Sacyr at €5.00 per share, while the most bearish prices it at €3.90. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Sacyr is an easy business to forecast or the the analysts are all using similar assumptions.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 0.2% by the end of 2026. This indicates a significant reduction from annual growth of 0.4% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.4% per year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Sacyr is expected to lag the wider industry.

The Bottom Line

The clear take away from these updates is that the analysts made no change to their revenue estimates for next year, with the business apparently performing in line with their models. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

At least one of Sacyr's nine analysts has provided estimates out to 2027, which can be seen for free on our platform here.

Even so, be aware that Sacyr is showing 2 warning signs in our investment analysis , and 1 of those doesn't sit too well with us...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.